INSIGHTS ON DRUG DEVELOPMENT

• Integrated QC As A Development Strategy: Reducing Late-Stage Analytical Risk

  Learn how early QC integration, proactive analytical risk management, and cross-functional collaboration can improve validation readiness, reduce development surprises, strengthen release testing predictability, and help protect critical clinical manufacturing timelines.

• UPLC-MS/MS Determination Of GLP-1 Analogue

  Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.

• Straight From The Source: A Live Q&A With The Inventors Of KinetiSol™

  Experts discuss a solvent-free fusion process for amorphous solid dispersions, highlighting formulation flexibility, scale-up, process control, and early strategies to reduce risk and support commercialization.

• Using AI-Analysis And High-Content Screening To Improve Data Capturing

  Discover an advanced 3D imaging for drug discovery that features high-throughput, high-quality images, modular hardware, and intuitive software for precise, rapid analysis.

• Lipid Nanoparticles For Pulmonary Delivery Of mRNA

  7/1/2026

  Gain insight into how nebulized mRNA lipid nanoparticles show preclinical success in lung delivery, offering fresh momentum for inhaled gene therapies targeting respiratory diseases.

• How CRISPR And LNP Accelerate Therapeutic Innovation Through Analytics

  9/2/2025

  CRISPR gene editing and lipid nanoparticle delivery are revolutionizing precision medicine. Discover how optimized LNP systems and advanced analytics accelerate therapeutic development.

• Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery

  6/3/2025

  Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.

• If Collaboration Fuels Biopharma Innovation, Why Can't We Connect More?

  3/17/2026

  Breakthroughs thrive when biopharma teams work across silos, yet collaboration remains surprisingly difficult. Explore the barriers and why they persist. What will it take to move beyond them?

• Lightning-Link^® Conjugation Kits: Consistent Performance On A Broad Scale

  9/26/2024

  Learn about labeling technology offering a transformative solution through direct antibody labeling without the need for post-conjugation purification, thereby mitigating antibody loss and ensuring reproducible results.